Life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months from most recent chemotherapy or immunotherapy treatmentXx_NEWLINE_xXNo comorbid conditions that would cause life expectancy of less than 5 yearsXx_NEWLINE_xXLife expectancy of < 12 months at screeningXx_NEWLINE_xXPatient must have a life expectancy of at least 3 months with appropriate therapyXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy > 3 months.Xx_NEWLINE_xXEstimated life expectancy of at least 3 months.Xx_NEWLINE_xXPatients with life expectancy of at least 12 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 9 monthsXx_NEWLINE_xXPatients must have a life expectancy > 3 monthsXx_NEWLINE_xXHave ECOG PS of 0 or 1 with an anticipated life expectancy of > 6 months.Xx_NEWLINE_xXLife expectancy of at least 3 months in the opinion of the investigatorXx_NEWLINE_xXEstimated life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXEstimated life expectancy of at least 90 daysXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXHas a life expectancy >3 months.Xx_NEWLINE_xXLife expectancy >/= 3 months, as determined by the investigator;Xx_NEWLINE_xXProcurement: Patients with life expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of ? 6 monthsXx_NEWLINE_xXLife expectancy <3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXHave an anticipated life expectancy of ?3 months.Xx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy <2 yearsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPredicted life expectancy of ?3 monthsXx_NEWLINE_xXLife Expectancy of at least 3 monthsXx_NEWLINE_xXSubject must have a life expectancy of > 3 months, in the Investigator's judgment;Xx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXMinimum life expectancy of 3 monthsXx_NEWLINE_xXLife expectancy > 4 monthsXx_NEWLINE_xXSAFETY RUN-IN: Life expectancy of less than 3 monthsXx_NEWLINE_xXRANDOMIZED PHASE II CLINICAL TRIAL: Life expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy ?3 months in the judgment of the investigator.Xx_NEWLINE_xXMinimum life expectancy of 3 monthsXx_NEWLINE_xXPredicted life expectancy of 3 months or moreXx_NEWLINE_xXLife expectancy less than (<) 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXEstimated life expectancy >= 3 months as determined by the treating physicianXx_NEWLINE_xXLife expectancy of at least six monthsXx_NEWLINE_xXHas a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least three months.Xx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy > 6 months per investigatorXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXAnticipated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXSubject must have a life expectancy >= 2 yearsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of < 1 yearXx_NEWLINE_xXLife expectancy > 4 monthsXx_NEWLINE_xXPatient with life expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy <12 monthsXx_NEWLINE_xXPatients whose life expectancy is limited by illness other than their neurological conditionXx_NEWLINE_xXPatients must have an estimated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >3 months, in the judgment of the investigator.Xx_NEWLINE_xXLife expectancy at least 3 months.Xx_NEWLINE_xXEstimated life expectancy of at least 3 months, in the judgment of the Investigator.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPHASE II INCLUSION CRITERIA: Life expectancy of at least 3 monthsXx_NEWLINE_xXHas a life expectancy of >3 monthsXx_NEWLINE_xXLife expectance of >= 3 monthsXx_NEWLINE_xXLife expectancy ?3 months, as determined by the investigatorXx_NEWLINE_xXLife expectancy of ?3 months.Xx_NEWLINE_xXLife expectancy >3 months as per investigator's assessment.Xx_NEWLINE_xXEvidence of immediate life-threatening disease or a life expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 12 months in the judgment of the physicianXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy <6 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXSubject has anticipated life expectancy > 6 months prior to leukapheresis and >3 months prior to lymphodepletion.Xx_NEWLINE_xXHas a life expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXPredicted life expectancy of ? 3 months.Xx_NEWLINE_xXPatients with short life expectancy (less than 3 months) due to comorbidity other than MDS or CMMLXx_NEWLINE_xXAnticipated life expectancy of more than 3 months per Investigator's judgementXx_NEWLINE_xXLife expectancy is > 6 monthsXx_NEWLINE_xXHas a life expectancy of >3 monthsXx_NEWLINE_xXLife expectancy ? 6 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXHas a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXHave a life expectancy of at least 3 monthsXx_NEWLINE_xXIn the opinion of the Investigator, the patient has a life expectancy of > 3 months.Xx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy >= 12 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy ?3 mosXx_NEWLINE_xXAnticipated life expectancy >= three monthsXx_NEWLINE_xXLife expectancy ?3 months.Xx_NEWLINE_xXLife expectancy of less than 6 months in the judgment of the study physician.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXExpected to have life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXPatients with a life expectancy < 3 months from co-existing disease other than the leukemia or RAEBXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXA life expectancy of at least 3 months as assessed by the Investigator.Xx_NEWLINE_xXEstimated life expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of ?3 monthsXx_NEWLINE_xXLife expectancy >= 90 daysXx_NEWLINE_xXLife expectancy > 2 monthsXx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXPatient must have a life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy > 6 months in opinion of InvestigatorXx_NEWLINE_xXPatients with a life expectancy of less than 2 yearsXx_NEWLINE_xXParticipants' life expectancy must be > 6 monthsXx_NEWLINE_xXLife expectancy > 2 monthsXx_NEWLINE_xXPatients with life expectancy < 4 months.Xx_NEWLINE_xXHave life expectancy of >/= 3 months;Xx_NEWLINE_xXNo active or co-existing malignancy with life expectancy less than 12 monthsXx_NEWLINE_xXLife expectancy of ? 6 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy less than 4 monthsXx_NEWLINE_xXLife expectancy of less than 6 months prior to randomizationXx_NEWLINE_xXNo active or co-existing malignancy with life expectancy less than 12 monthsXx_NEWLINE_xXHave an investigator determined life expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of at least three months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of 12 monthsXx_NEWLINE_xXLife expectancy >= 90 daysXx_NEWLINE_xXLife expectancy of at least 4 months.Xx_NEWLINE_xXHas a life expectancy of ?3 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy >=3 monthsXx_NEWLINE_xXEstimated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of > 2 monthsXx_NEWLINE_xXLife expectancy of at least 3-6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy ? 6 monthsXx_NEWLINE_xXLife expectancy > 12 monthsXx_NEWLINE_xXEstimated life expectancy of >= 6 monthsXx_NEWLINE_xXEstimated life expectancy of >= 12 months at screeningXx_NEWLINE_xXLife expectancy at least 3 monthsXx_NEWLINE_xXHave a life expectancy of at least 6 monthsXx_NEWLINE_xXCo-existing medical conditions with life expectancy < 5 yearsXx_NEWLINE_xXLife expectancy of > 3 months.Xx_NEWLINE_xXEstimated life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXPatients with a life expectancy of < 3 months of enrollment from coexisting disease other than leukemiaXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of > 12 months (exclusive of the disease for which the auto HSCT is being performed)Xx_NEWLINE_xXLife expectancy less than 10 years;Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPatients must have life expectancy > 6 months.Xx_NEWLINE_xXLife expectancy of at least 2 yearsXx_NEWLINE_xXLife expectancy ?3 months in the judgement of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 months, in the opinion of the investigator.Xx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy > 3 months;Xx_NEWLINE_xXHave a life expectancy of at least 3 months, in the opinion of the investigator.Xx_NEWLINE_xXLife expectancy >= 12 monthsXx_NEWLINE_xXLife expectancy >= 2 months at the time of study drug administrationXx_NEWLINE_xXHave a life expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy >6 months at time of screening.Xx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy >= 12 monthsXx_NEWLINE_xXPatient must have a minimal life expectancy of at least 6 monthsXx_NEWLINE_xXHave an investigator determined life expectancy of at least 6 monthsXx_NEWLINE_xXPatients with any severe concomitant disease that may limit their life expectancy to less than 5 yearsXx_NEWLINE_xXPatients must have a life expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy of ? 6 months from the first OBP-301 treatment.Xx_NEWLINE_xXlife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of over 3 months as determined by treating physicianXx_NEWLINE_xXEstimated life expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy less than 2 yearsXx_NEWLINE_xXLife expectancy of 3 months or more as assessed by the investigatorXx_NEWLINE_xXLife expectancy at least 4 monthsXx_NEWLINE_xXPatients with life expectancy less than 6 months, ECOG > 3Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXEstimated life expectancy of ? 6 months as assessed by the investigator.Xx_NEWLINE_xXPatients with short life expectancy (less than 3 months) due to comorbidity other than MDSXx_NEWLINE_xXSubject has anticipated life expectancy > 6 months prior to leukapheresis and >3 months prior to lymphodepletion.Xx_NEWLINE_xXLife expectancy of > 12 monthsXx_NEWLINE_xXLife expectancy > 3 months;Xx_NEWLINE_xXECOG Grade 0 - 2, with minimum life expectancy of at least 3 months;Xx_NEWLINE_xXLife expectancy at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 8 weeks (2 months)Xx_NEWLINE_xXLife expectancy of at least 24 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months;Xx_NEWLINE_xXLife expectancy of at least 3 months at the time of screening as judged by the investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPatient must have a life expectancy >= 9 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXEstimated life expectancy of more than 6 monthsXx_NEWLINE_xXHave estimated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXPRE-SCREENING: Life expectancy of at least 3 monthsXx_NEWLINE_xXFULL STUDY INCLUSION CRITERIA: Life expectancy of at least 3 monthsXx_NEWLINE_xXPatients must have a life expectancy >= 6 monthsXx_NEWLINE_xXSubject has an ECOG Performance Status 0-1 and anticipated life expectancy >6 months prior to apheresis and >3 months prior to lymphodepletion.Xx_NEWLINE_xXLife expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy of > 4 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXSubjects must have a life expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXHas life expectancy >= 3 monthsXx_NEWLINE_xXHave at least 6 month life expectancyXx_NEWLINE_xXLife expectancy of > 6 monthsXx_NEWLINE_xXHave at least 6 months life expectancyXx_NEWLINE_xXLife expectancy of at least 3 months in the opinion of investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXSubjects must have a reasonable life expectancy of at least 2 monthsXx_NEWLINE_xXHave a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 6 months prior to enrollment.Xx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXPredicted life expectancy of at least 3 months;Xx_NEWLINE_xXLife expectancy =< 4 months in the judgment of the treating clinicianXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXAt screening, life expectancy of at least 3 months.Xx_NEWLINE_xXSubjects with life expectancy less than 3 months.Xx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXSubjects with life expectancy < 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXPatients with a life expectancy of < 3 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy >= 10 years (as determined by the treating physician)Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of less than 6 months.Xx_NEWLINE_xXPatients must have a life expectancy of >= 2 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXPatients with life expectancy < 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of 12 months or longerXx_NEWLINE_xXHave an investigator determined life expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy less than 3 monthsXx_NEWLINE_xXLife expectancy: at least 6 monthsXx_NEWLINE_xXSubjects must have an estimated life expectancy of at least 3 monthsXx_NEWLINE_xXPatient has an estimated life expectancy of at least 6 months.Xx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy ? 6 months.Xx_NEWLINE_xXPatients should have estimated life expectancy of > 3 months at study entryXx_NEWLINE_xXHave a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXHave a predicted life expectancy of ? 3 monthsXx_NEWLINE_xXHas a life expectancy of >3 monthsXx_NEWLINE_xXHave a life expectancy of at least 6 months, as estimated by the investigatorXx_NEWLINE_xXPatients must have a life expectancy of > 3 monthsXx_NEWLINE_xXPatients must have a life expectancy of > 3 monthsXx_NEWLINE_xXPatients must have a life expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy less than 3 monthsXx_NEWLINE_xXPatients must have a life expectancy of > 3 monthsXx_NEWLINE_xXNo active or co-existing malignancy with life expectancy less than 12 monthsXx_NEWLINE_xXLife expectancy < 6 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXHave estimated life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy of 6 months or longerXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXHave a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXEstimated life expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy less than 4 monthsXx_NEWLINE_xXHas a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy with treatment should be >= 6 months in the estimation of the treating physiciansXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPredicted life expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXEstimated life expectancy of more than 6 monthsXx_NEWLINE_xXLife expectancy of >= 2 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 5 yearsXx_NEWLINE_xXLife expectancy of >= 3 years (yrs)Xx_NEWLINE_xXPatient is ambulatory with an ECOG performance status of 0, 1 or 2 and an estimated life expectancy of > 3 months.Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 2 monthsXx_NEWLINE_xXLife expectancy less than 2 monthsXx_NEWLINE_xXSubjects with life expectancy < 6 monthsXx_NEWLINE_xXEstimated life expectancy > 6 months and not expected to require further systemic chemotherapy for at least 3 monthsXx_NEWLINE_xXLife expectancy > 5 yearsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXPatients with a life expectancy of < 3 monthsXx_NEWLINE_xXMust have a life expectancy of at least 5 years based on age and co-morbidities.Xx_NEWLINE_xXLife expectancy less than 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy > 12 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXAble to attend all study visits (i.e., life expectancy of at least 3 months).Xx_NEWLINE_xXLife expectancy of >= 12 months as determined by treating investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >/= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXNo life expectancy restrictions will applyXx_NEWLINE_xXLife expectancy severely limited by disease other than malignancyXx_NEWLINE_xXLife expectancy of >= 10 years as determined by treating physicianXx_NEWLINE_xXPatients with co-existing medical conditions with life expectancy < 2 yearsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXA serious underlying medical condition other than NSCLC such that life expectancy is less than 2 years.Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 months.Xx_NEWLINE_xXLife expectancy estimated to be at least 3 months;Xx_NEWLINE_xXHave a life expectancy of at least 3 months;Xx_NEWLINE_xXSubject has estimated life expectancy of at least 3 monthsXx_NEWLINE_xXlife expectancy of less than 6 months; Related to anticoagulant treatment:Xx_NEWLINE_xXLife expectancy of at least 9 monthsXx_NEWLINE_xXLife expectancy of at least 9 monthsXx_NEWLINE_xXLife expectancy ? 4 months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXSubject has a life expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of less than 6 months.Xx_NEWLINE_xXHas a life expectancy of ?3 months.Xx_NEWLINE_xXPatients must have a life expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least three monthsXx_NEWLINE_xXLife expectancy of at least 90 daysXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPatients with life expectancy < 6-MonthsXx_NEWLINE_xXStable clinical conditions and life expectancy > 3 monthsXx_NEWLINE_xXEstimated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >3 months;Xx_NEWLINE_xXLife expectancy of >3 monthsXx_NEWLINE_xXAble to attend all study visits (i.e. life expectancy of at least 3 months).Xx_NEWLINE_xXLife expectancy of >= 1 yearXx_NEWLINE_xXEstimated Life Expectancy > 3 months;Xx_NEWLINE_xXParticipant has a life expectancy of >= 3 months.Xx_NEWLINE_xXLife expectancy must be ? 3 months.Xx_NEWLINE_xXSevere, active co-morbidity defined as follows:\r\n* Life expectancy < 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXAnticipated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy < 6 months (m) for any causeXx_NEWLINE_xXLife expectancy must be > 3 monthsXx_NEWLINE_xXMust have an average life expectancy of 6 monthsXx_NEWLINE_xXLife expectancy > 6 months.Xx_NEWLINE_xXLife expectancy less than 3 monthsXx_NEWLINE_xXOther life-threatening illness that is expected to impact life expectancy within 3 yearsXx_NEWLINE_xXPatient has a life expectancy of at least 3 months in the opinion of the investigator.Xx_NEWLINE_xXSubjects with life expectancy < 6 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of >= 4 months in the attending physician’s estimationXx_NEWLINE_xXLife expectancy estimate > 3 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least three months.Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of > 5 years per the clinical impression of the treating physician(s)Xx_NEWLINE_xXSubjects must have an estimated life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 6 months as assessed by study physicianXx_NEWLINE_xXPatient must have a life expectancy of at least 3 months with appropriate therapyXx_NEWLINE_xXTUMOR BIOPSY SEQUENCING: Life expectancy > 3 monthsXx_NEWLINE_xXTREATMENT: Life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of >= 2 yearsXx_NEWLINE_xXLife expectancy more than 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy (untreated) of > 4 months, in the opinion of and as documented by the investigatorXx_NEWLINE_xXMinimum expected life expectancy > 6 monthsXx_NEWLINE_xXLife expectancy >= 90 days (3 months)Xx_NEWLINE_xXPatients whose life expectancy is severely limited by illness other than CDXx_NEWLINE_xXThe subject has an estimated life expectancy of more than three monthsXx_NEWLINE_xXPatients whose life expectancy is limited by diseases other than their malignancyXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXSubjects with life expectancy of at least 4 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy < 6 months based on judgement of investigatorXx_NEWLINE_xXPatients should have estimated life expectancy of > 3 months at study entryXx_NEWLINE_xX< 10 years life expectancyXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXEstimated life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy >= 6 months after transplantXx_NEWLINE_xXLife expectancy < 6 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXPatient has a life expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months in the opinion of investigatorXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXWith life expectancy severely limited by diseases other than malignancyXx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy less than 3 monthsXx_NEWLINE_xXLife expectancy < 10 yearsXx_NEWLINE_xXLife expectancy >= 84 days (3 months)Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of < 2 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy >2 years, in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXHas a life expectancy of >3 monthsXx_NEWLINE_xXHas a predicted life expectancy >3 months.Xx_NEWLINE_xXLife expectancy of at least 6 months based on Investigator´s judgment.Xx_NEWLINE_xXLife expectancy >3 months.Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXHave a life expectancy of ?3 months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXEstimated Life Expectancy of at least 3 moXx_NEWLINE_xXLife expectancy of ? 3 months.Xx_NEWLINE_xXLife expectancy >= 3 months.Xx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy ? 10 yearsXx_NEWLINE_xXHas a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of ? 6 months per the investigator.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXProjected life expectancy must be at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 12 months as per the investigator's judgmentXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 5 years, disregarding the diagnosis of cancer;Xx_NEWLINE_xXLife expectancy >=3 months, in the investigator's judgmentXx_NEWLINE_xXLife expectancy of ? 6 months per the investigatorXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXEstimated life expectancy ? 12 months.Xx_NEWLINE_xXLife expectancy severely limited by diseases other than malignancyXx_NEWLINE_xXPredicted life expectancy of 3 or more monthsXx_NEWLINE_xXHas a life expectancy of >3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy >= 84 days (3 months)Xx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXECOG Performance Status 0-1 and anticipated life expectancy > 3 months.Xx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXHave an anticipated life expectancy of ?3 months.Xx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXExpected to have life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy estimated at ? 3 months.Xx_NEWLINE_xXHave a life expectancy of ? 3 months.Xx_NEWLINE_xXLife expectancy of at least twelve months;Xx_NEWLINE_xXLife expectancy of ?6 monthsXx_NEWLINE_xXLife expectancy ? 10 years.Xx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy of ? 3 months, in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of >=3 months.Xx_NEWLINE_xXHas a predicted life expectancy >3 monthsXx_NEWLINE_xXA life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > = 3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy >= 2 months at the time of study drug administrationXx_NEWLINE_xXLife expectancy less than 4 monthsXx_NEWLINE_xXHave a life expectancy of at least 3 months, as estimated by the investigatorXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXEstimated life expectancy >6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 2 monthsXx_NEWLINE_xXLife expectancy > 3 months in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least three months.Xx_NEWLINE_xXLife expectancy < 6 months.Xx_NEWLINE_xXLife expectancy of at least 3 months in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 5 yearsXx_NEWLINE_xXLife expectancy < 90 days.Xx_NEWLINE_xXPerformance status: ECOG ? 1 and life expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy >= 4 monthsXx_NEWLINE_xXLife expectancy of > 4 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXHave ECOG PS of 0 or 1 with an anticipated life expectancy of > 6 months.Xx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife Expectancy of at least 3 monthsXx_NEWLINE_xXPatients must have an anticipated life expectancy > 3 months.Xx_NEWLINE_xXLife expectancy of >3 months as estimated by the investigatorXx_NEWLINE_xXLife expectancy of at least 1 yearXx_NEWLINE_xXPatients must have a life expectancy of >= 90 daysXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy at least 3 monthsXx_NEWLINE_xXHave a life expectancy of ?3 months.Xx_NEWLINE_xXSubject has a life expectancy of less than 3 months;Xx_NEWLINE_xXLife expectancy < 3 monthsXx_NEWLINE_xXPatient must have a life expectancy >= 12 monthsXx_NEWLINE_xXEstimated life expectancy >= 84 days (3 months)Xx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy < 6 months as assessed by the treating physicianXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of < 3 monthsXx_NEWLINE_xXSubject has an estimated life expectancy of at least 3 months on Day 1, in the opinion of the investigator.Xx_NEWLINE_xXLife expectancy less than 6 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXAnticipated life expectancy >= 6 monthsXx_NEWLINE_xXThe participant has, in the opinion of the investigator, a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of less than 12 months.Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXEstimated life expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy > 5 yearsXx_NEWLINE_xXEstimated life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of <3 months and/or has rapidly progressing diseaseXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPatient has a predicted life-expectancy of ?3 months.Xx_NEWLINE_xXLife expectancy >6 monthsXx_NEWLINE_xXPatients must have a life expectancy of 3 months or longerXx_NEWLINE_xXLife expectancy of > 3 months (in the opinion of the investigator)Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy less than 36 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXPatients must have a life expectancy of at least one yearXx_NEWLINE_xXPatients have a life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy >= 4 monthsXx_NEWLINE_xXParticipants’ life expectancy must be > 4 monthsXx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXHave a life expectancy ?3 months.Xx_NEWLINE_xXA life expectancy at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of 6 months or lessXx_NEWLINE_xXLife expectancy of >= 12 monthsXx_NEWLINE_xXPatients must have a life expectancy >= 90 daysXx_NEWLINE_xXLife expectancy ?6 monthsXx_NEWLINE_xXLife expectancy estimated at ?3 months.Xx_NEWLINE_xXLife expectancy >= 3 months as determined by the treating physicianXx_NEWLINE_xXLife expectancy > 1 monthXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXEstimated life expectancy of ? 12 monthsXx_NEWLINE_xXLife expectancy < 3 yearsXx_NEWLINE_xXIn the opinion of the Investigator, life expectancy > 6 months.Xx_NEWLINE_xXLife expectancy of 3 or less monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXEstimated life expectancy of >= 5 yearsXx_NEWLINE_xXSubjects must have a life expectancy of > 6 monthsXx_NEWLINE_xXLife expectancy of at least three (3) monthsXx_NEWLINE_xXAt least 6-month life expectancy.Xx_NEWLINE_xXLife expectancy > 10 years based on clinician’s judgmentXx_NEWLINE_xXHas a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of >= 12 months as determined by treating investigatorXx_NEWLINE_xXPART B: Life expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy less than 1 monthXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months in opinion of treating investigatorXx_NEWLINE_xXPatients with a life expectancy < 3 months from co-existing disease other than the leukemia or RAEBXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy less than 3 monthsXx_NEWLINE_xXLife expectancy >= 3 mosXx_NEWLINE_xXLife expectancy less than 2 monthsXx_NEWLINE_xXLife expectancy =< 3 monthsXx_NEWLINE_xXExpected life expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy >/= 12 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXPredicted life expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife-expectancy based on comorbid conditions > 2 yearsXx_NEWLINE_xXLife expectancy of at least 3 months in the opinion of investigatorXx_NEWLINE_xXPatient must have a life expectancy >= 9 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy of < 3 months;Xx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXPatient must have a life expectancy of at least 2 monthsXx_NEWLINE_xXEstimated life expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of > 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy from a co-morbid illness > 3 yearsXx_NEWLINE_xXLife expectancy > 12 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy of > 4 monthsXx_NEWLINE_xXLife expectancy of >= 12 monthsXx_NEWLINE_xXLife expectancy >= three monthsXx_NEWLINE_xXLife expectancy >= 6 months; this must be documentedXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of ? 6 monthsXx_NEWLINE_xXPatients must have a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXAnticipated life expectancy of at least three months;Xx_NEWLINE_xXLife expectancy <12 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy > 3 months as assessed by the investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy ?3 monthsXx_NEWLINE_xXLife expectancy of at least 3 yearsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXMinimum life expectancy of ?3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXA life expectancy of at least 3 monthsXx_NEWLINE_xXHave a life-expectancy ?3 monthsXx_NEWLINE_xXSubject has a life expectancy of > 6 monthsXx_NEWLINE_xXECOG performance status of 0 to 1 at trial entry and estimated life expectancy of ?3 months.Xx_NEWLINE_xXECOG performance status of 0 to 1 at trial entry and estimated life expectancy of ?3 months.Xx_NEWLINE_xXHas a life expectancy of ?3 monthsXx_NEWLINE_xXLife expectancy of more than 6 months, in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of > 3 months, in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months;Xx_NEWLINE_xXPatients with distant metastasis and life expectancy >= 3 months are eligibleXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of at least 2 monthsXx_NEWLINE_xXLife expectancy severely limited by diseases other than malignancyXx_NEWLINE_xXlife expectancy > 12 months.Xx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXEstimated life expectancy of > 6 monthsXx_NEWLINE_xXLife expectancy severely limited by disease other than lymphomaXx_NEWLINE_xXLife expectancy ?3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy < 4 months;Xx_NEWLINE_xXAn estimated life expectancy of at least 3 monthsXx_NEWLINE_xXHas a life expectancy ? 6 monthsXx_NEWLINE_xXLife expectancy of ? 2 months,Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXPredicted life expectancy of ? 3 months.Xx_NEWLINE_xXEvidence of immediately life-threatening disease, progressively fatal disease, or life expectancy of 3 months or less.Xx_NEWLINE_xXLife expectancy ?3 monthsXx_NEWLINE_xXEstimated life expectancy of > 6 monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXAnticipated life expectancy >3 months at the time of screeningXx_NEWLINE_xXLife expectancy of 3 >= monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXAnticipated life expectancy >3 months at the time of screeningXx_NEWLINE_xXEstimated life expectancy of ? 6 months at screening.Xx_NEWLINE_xXLife expectancy >= 3 months and performance status of at least 70%Xx_NEWLINE_xXLife-expectancy of at least 60 daysXx_NEWLINE_xXPatients must have a life expectancy of > 3 months, in the opinion of and as documented by the investigatorXx_NEWLINE_xXEstimated life expectancy of at least 3 monthsXx_NEWLINE_xXPatients with life expectancy < 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXEstimated life expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy >= 12 monthsXx_NEWLINE_xXLife expectancy >= 2 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of 6 months or moreXx_NEWLINE_xXLife expectancy of at least 6 months in the judgment of the physicianXx_NEWLINE_xXLife expectancy < 6 monthsXx_NEWLINE_xXhave an estimated life expectancy of >3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xX8. Life expectancy ?3 months.Xx_NEWLINE_xXIn the opinion of the investigator, the participants have a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy > 4 monthsXx_NEWLINE_xXLife expectancy >= 2 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXHas a life expectancy of at least 3 monthsXx_NEWLINE_xXPatients with life expectancy less than 12 months will be excludedXx_NEWLINE_xXLife expectancy < 3 monthsXx_NEWLINE_xXHas life expectancy of less than 3 months.Xx_NEWLINE_xXLife expectancy <3 monthsXx_NEWLINE_xXHave a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy >6 monthsXx_NEWLINE_xXLife expectancy of >=3 months.Xx_NEWLINE_xXLife expectancy ?3 months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXPatients must have a life expectancy of > 6 monthsXx_NEWLINE_xXPatients must have a life expectancy of > 6 monthsXx_NEWLINE_xXPatients with life expectancy < 6 monthsXx_NEWLINE_xXEstimated life expectancy of ? 3 months.Xx_NEWLINE_xXLife expectancy less than one yearXx_NEWLINE_xXLife expectancy of at least 2 monthsXx_NEWLINE_xXPredicted life expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXPatient has a life expectancy of at least 4 months.Xx_NEWLINE_xXPatients with a life expectancy of < 6 months.Xx_NEWLINE_xXLife expectancy >6mo.Xx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXEstimated life expectancy of at least 6 months, in the Investigator's opinionXx_NEWLINE_xXLife expectancy of at least three months.Xx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXSubject has a life expectancy of more than 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXMinimum life expectancy of 3 months;Xx_NEWLINE_xXPatients should have estimated life expectancy of > 3 months at study entryXx_NEWLINE_xXPatients must have a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 months, in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXSubject has a life expectancy of at least 12 months as assessed by the investigatorXx_NEWLINE_xXLife expectancy: > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months as judged by the investigatorXx_NEWLINE_xXSubjects must have a life expectancy of at least 3 monthsXx_NEWLINE_xXPatient must have a life expectancy of >= 3 months, as estimated by the treating oncologistXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy < 3 months in the opinion of the InvestigatorXx_NEWLINE_xXLife Expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months as assessed by the investigatorXx_NEWLINE_xXLife expectancy of ? three months.Xx_NEWLINE_xXLife expectancy > 3 months;Xx_NEWLINE_xXLife expectancy of >3 months, in the opinion of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXEstimated life expectancy of at least 3 monthsXx_NEWLINE_xXPatients must have a predicted life expectancy of more than 3 months.Xx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy >= 12 monthsXx_NEWLINE_xXLife expectancy of > 6 monthsXx_NEWLINE_xXLife Expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of ? 2 months.Xx_NEWLINE_xXLife expectancy less than 6 monthsXx_NEWLINE_xXEstimated life expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy at least 6 monthsXx_NEWLINE_xXPatients with an estimated life expectancy of less than 3 months as determined by the treating physicianXx_NEWLINE_xXEstimated life expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXAnticipated life expectancy > 3 months at the time of screeningXx_NEWLINE_xXLife expectancy > 2 monthsXx_NEWLINE_xXPredicted life expectancy of ?3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy of more than 5 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy of at least 4 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXPatient’s life expectancy is >= 10 yearsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy 4 months or less as estimated by the investigator.Xx_NEWLINE_xXLife expectancy of > 3 months for the run in phase and > 6 months for the randomized phaseXx_NEWLINE_xXLife expectancy of less than 6 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of 3 or less monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXLife expectancy of at least 2 monthsXx_NEWLINE_xXLife expectancy of at least 1 monthXx_NEWLINE_xXLife expectancy of at least 6 months in the opinion of the investigator.Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 6 months in the opinion of the investigator.Xx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy < 3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy >3 monthsXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXEstimated life expectancy >=6 monthsXx_NEWLINE_xXLife expectancy of at least three months.Xx_NEWLINE_xXThe participant has a life expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy of at least 3 months without any active treatment.Xx_NEWLINE_xXLife expectancy >= 4 monthsXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy >3 months assessed during ScreeningXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy < 6 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of at least 12 months in the judgment of the physicianXx_NEWLINE_xXLife expectancy of at least 12 monthsXx_NEWLINE_xXHave an expected life expectancy of at least 5 monthsXx_NEWLINE_xXHas a life expectancy >3 monthsXx_NEWLINE_xXNo co-existing medical conditions with life expectancy < 5 yearsXx_NEWLINE_xXPatients with a life expectancy of more than 3 monthsXx_NEWLINE_xXA life expectancy of at least 12 monthsXx_NEWLINE_xXLife expectance of at least three monthsXx_NEWLINE_xXPATIENT EXCLUSION: Life expectancy of < 1 monthXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXPatients with life expectancy < 3-MonthsXx_NEWLINE_xXLess than six months life expectancyXx_NEWLINE_xXLife expectancy estimated at > 12 monthsXx_NEWLINE_xXLife expectancy of >= 12 monthsXx_NEWLINE_xXPatients must have a life expectancy of 100 daysXx_NEWLINE_xXExpected life expectancy of ? 3 months.Xx_NEWLINE_xXExpected life expectancy of ? 3 months.Xx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXPredicted life expectancy of at least 12 monthsXx_NEWLINE_xXMust have a life expectancy > 5 daysXx_NEWLINE_xXThere are no restrictions related to performance status or life expectancyXx_NEWLINE_xXHave a life expectancy of < 12 months or are receiving hospice servicesXx_NEWLINE_xXEstimated life expectancy of > 4 months at the time of screeningXx_NEWLINE_xXPatients with a life expectancy of =< 6 months, as determined by their oncology providers, will be excludedXx_NEWLINE_xXLife expectancy of at least 6 monthsXx_NEWLINE_xXHaving a life expectancy of at least 12 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy < 6 monthsXx_NEWLINE_xXPatient must have an estimated life expectancy >= 4 months in the opinion of the investigatorsXx_NEWLINE_xXHas a life expectancy of > 6 monthsXx_NEWLINE_xXPatients are eligible regardless of life expectancyXx_NEWLINE_xXA life expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy < 6 monthsXx_NEWLINE_xXHaving a life expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy >= 3 months (90 days)Xx_NEWLINE_xXLife expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXPATIENTS ONLY: Physician-rated life expectancy of less than 6 monthsXx_NEWLINE_xXAttending physician assessment of prognosis with expected life expectancy of > 2 monthsXx_NEWLINE_xXNo life expectancy restrictionXx_NEWLINE_xXPHASE I AIM 1: Life expectancy of at least six monthsXx_NEWLINE_xXPHASE I AIM 3.1: Life expectancy of at least six monthsXx_NEWLINE_xXPHASE I AIM 3.2: Life expectancy of at least six monthsXx_NEWLINE_xXPHASE II AIM 2: Life expectancy of at least six monthsXx_NEWLINE_xXProjected life expectancy of at least 3 monthsXx_NEWLINE_xXThere are no restrictions related to performance status or life expectancyXx_NEWLINE_xXHas a life expectancy of 12 months or longer; all cancer types are includedXx_NEWLINE_xXThere are no restrictions related to performance status and life expectancyXx_NEWLINE_xXHaving a life expectancy of at least 12 monthsXx_NEWLINE_xXLife expectancy >= 9 months as estimated by their treating oncologistXx_NEWLINE_xXHave a life expectancy of >= 3monthsXx_NEWLINE_xXHave a life expectancy of >= 3monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of < 6 monthsXx_NEWLINE_xXA life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of at least one yearXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of >= 4 monthsXx_NEWLINE_xXLife expectancy >= 60 daysXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXHave a life expectancy >12 months from the anticipated time of initiation of treatmentXx_NEWLINE_xXLIfe expectancy >=3 months, as determined by the investigatorXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXHave an estimated life expectancy > 4 monthsXx_NEWLINE_xXAt screening, life expectancy of at least 3 months;Xx_NEWLINE_xXParticipants must have a life expectancy of 2 years or moreXx_NEWLINE_xXLife expectancy estimated to be at least 2 yearsXx_NEWLINE_xXPatients should have a life expectancy of at least 1 yearXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy < 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXSubjects must have a life expectancy of at least 4 monthsXx_NEWLINE_xX>= 12 months life expectancy (physician estimate)Xx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXNo restrictions will be made based on life expectancyXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXHave life expectancy of at least 6 monthsXx_NEWLINE_xXLife expectancy of >= 12 months;Xx_NEWLINE_xXA life expectancy of less than 12 months;Xx_NEWLINE_xXLife expectancy of < 3 monthsXx_NEWLINE_xXLife expectancy ? 2 monthsXx_NEWLINE_xXWHO/ECOG performance score > 2 and life expectancy of < 6 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXPatients must have a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy less than 5 yearsXx_NEWLINE_xXPatients with a life expectancy of less than one yearXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXSubjects enrolled in hospice or whose life expectancy is less than 6 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of less than 3 monthsXx_NEWLINE_xXSubjects with a life expectancy less than study duration;Xx_NEWLINE_xXLife Expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 6 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy ? 3 monthsXx_NEWLINE_xXLife expectancy <2 months or Lansky score <50%Xx_NEWLINE_xXLife expectancy of >= 5 yearsXx_NEWLINE_xXLife expectancy of < 6 monthsXx_NEWLINE_xXLife expectancy less than five years.Xx_NEWLINE_xXHas a predicted life expectancy ?3 monthsXx_NEWLINE_xXLife expectancy must be estimated by patient’s physician at > 6 monthsXx_NEWLINE_xXPatients with anticipated life expectancy < 3 months will be excludedXx_NEWLINE_xXLife expectancy less than 6 monthsXx_NEWLINE_xXLife expectancy of less than 6 monthsXx_NEWLINE_xXPatient must have a life expectancy of >= 3 monthsXx_NEWLINE_xX(Part 3, suspected recurrent GBM patients ONLY): Life expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy < 3 months (mo)Xx_NEWLINE_xXLife expectancy must be estimated at > 6 months.Xx_NEWLINE_xXLife expectancy of at least one yearXx_NEWLINE_xXLife expectancy >= 6 monthsXx_NEWLINE_xXLife expectancy of less than one year.Xx_NEWLINE_xXThe patient should have a life expectancy of > 6 monthsXx_NEWLINE_xXLife expectancy < 3 monthsXx_NEWLINE_xXLife expectancy of at least three (3) monthsXx_NEWLINE_xXLife expectancy >= 2 yearsXx_NEWLINE_xXPatients must have a life expectancy of > 2 monthsXx_NEWLINE_xXGroup I: Life expectancy >= 1 yearXx_NEWLINE_xXGroup II: Life expectancy >= 1 yearXx_NEWLINE_xXGroup III: Life expectancy >= 1 yearXx_NEWLINE_xXLife expectancy of >= 3 monthsXx_NEWLINE_xXLife expectancy > six monthsXx_NEWLINE_xXThere are no life expectancy restrictionsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy >= 3 monthsXx_NEWLINE_xXLife expectancy of > 4 monthsXx_NEWLINE_xXLife expectancy of < 4 months.Xx_NEWLINE_xXHas a life expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy of > 3 monthsXx_NEWLINE_xXLife expectancy of ? 6 monthsXx_NEWLINE_xXIndividuals with a short life expectancy (< 10 years)Xx_NEWLINE_xXHave a life expectancy of 6 monthsXx_NEWLINE_xXLife expectancy < 3 monthsXx_NEWLINE_xXThere are no restrictions on life expectancyXx_NEWLINE_xXLife expectancy is not a consideration for protocol entryXx_NEWLINE_xXLife expectancy of =< six monthsXx_NEWLINE_xXSubject’s life expectancy must be >= 6 monthsXx_NEWLINE_xXLife expectancy of less than two monthsXx_NEWLINE_xXLife expectancy of >= 6 months (as determined by treating physician)Xx_NEWLINE_xXEstimated life expectancy of >= 6 monthsXx_NEWLINE_xXLife expectancy < 3 months, in the opinion of the Investigator.Xx_NEWLINE_xXEstimated life expectancy of at least 12 monthsXx_NEWLINE_xXLife expectancy >/= 6 monthsXx_NEWLINE_xXA referring physicians estimate of patient life expectancy must be between 1-12 monthsXx_NEWLINE_xXLife expectancy ? 3 months.Xx_NEWLINE_xXThe patient has a life expectancy of > 3 months.Xx_NEWLINE_xXPatients with life expectancy of at least 12 months and who are expected to be able to complete the full follow-up assessment in the protocol.Xx_NEWLINE_xXHas a life expectancy of at least 3 months.Xx_NEWLINE_xXLife expectancy > 4 months from the date of enrollment.Xx_NEWLINE_xXMinimum life expectancy of 3 months per the judgment of the investigatorXx_NEWLINE_xXLife expectancy of at least 3 monthsXx_NEWLINE_xXLife expectancy > 3 monthsXx_NEWLINE_xXLife expectancy of ? 3 monthsXx_NEWLINE_xX